Article
Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance.
Anti-cancer drugs - 1 Dec 1993
Dong Q G, Gong L L, Wang H J, Wang E Z
Abstract excerpt
We developed a mitomycin C (MMC)-resistant human lung adenocarcinoma cell subline, SPC-A1/DM4, from cloned SPC-A1/D13 parent cells by 1 h exposures to escalating concentrations of the drug over 17 months. A 5.9-fold resistance to MMC and a 3.8-fold cross-resistance to cisplatin were present in resistant cells compared with parent cells. This phenotype was stable in the absence of drug exposure for at least 6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
